Diagnostic Electron Microscopy a TEXT/ATLAS

Total Page:16

File Type:pdf, Size:1020Kb

Diagnostic Electron Microscopy a TEXT/ATLAS Diagnostic Electron Microscopy A TEXT/ATLAS Second Edition Springer New York Berlin Heidelberg Barcelona Hong Kong London Milan Paris Singapore Tokyo G. Richard Dickersin, M.D. Associate Professor of Pathology Harvard Medical School Associate Professor of Pathology Massachusetts Institute of Technology Pathologist Head of Diagnostic Electron Microscopy Unit Massachusetts General Hospital Boston, Massachusetts Diagnostic Electron Microscopy A TEXT/ATLAS Second Edition With 894 Illustrations G. Richard Dickersin, M.D. Pathologist and Head, Electron Microscopy Unit Department of Pathology Massachusetts General Hospital Boston, MA 02114-2617 USA and Associate Professor of Pathology Harvard Medical School Boston, MA 02115-6092 USA and Associate Professor of Pathology Massachusetts Institute of Technology Cambridge, MA 02139 USA Library of Congress Cataloging-in-Publication Data Dickersin, G. Richard. Diagnostic electron microscopy : a text/atlas / G. Richard Dickersin. — 2nd ed. p. cm. Includes bibliographical references and index. ISBN 0-387-98388-0 (hardcover : alk. paper) 1. Diagnosis, Electron microscopic. 2. Tumors—Diagnosis. I. Title. [DNLM: 1. Microscopy, Electron—methods Atlases. 2. Neoplasms— ultrastructure Atlases. 3. Cytodiagnosis—methods Atlases. 4. Kidney Glomerulus—ultrastructure Atlases. 5. Metabolic Diseases—pathology Atlases. 6. Neuromuscular Diseases—pathology Atlases. QZ 17 D549d 1999] RB43.5.D55 1999 616.07Ј58—dc21 DNLM/DLC 99-32439 Printed on acid-free paper. ©2000 by Springer-Verlag New York, Inc. All rights reserved. This work may not be translated or copied in whole or in part without the written permission of the publisher (Springer-Verlag New York, Inc., 175 Fifth Avenue, New York, NY 10010, USA), except for brief excerpts in connection with reviews or scholarly analysis. Use in connection with any form of information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed is forbidden. The use of general descriptive names, trade names, trademarks, etc., in this publication, even if the for- mer are not especially identified, is not to be taken as a sign that such names, as understood by the Trade Marks and Merchandise Marks Act, may accordingly be used freely by anyone. While the advice and information in this book are believed to be true and accurate at the date of going to press, neither the authors nor the editors nor the publisher can accept any legal responsibility for any errors or omissions that may be made. The publisher makes no warranty, express or implied, with re- spect to the material contained herein. Production coordinated by Impressions Book and Journal Services, Inc., managed by Terry Kornak, and manufacturing supervised by Jacqui Ashri. Typeset by Impressions Book and Journal Services, Inc., Madison, WI. Printed and bound by Maple-Vail Book Manufacturing Group, York, PA. Printed in the United States of America. 987654321 ISBN 0-387-98388-0 Springer-Verlag New York Berlin Heidelberg SPIN 10656887 To my wife, Barbara; my daughters, Kay, Gail, Leslie, and Amy; and my son, Ged. Ten years have elapsed since the appearance of the first edition of this book, and since then a number of ad- vances have been made in the field of diagnostic pathol- ogy. New and improved techniques have contributed to our diagnostic armamentarium and to our general understanding of various disease processes. In the field of neoplasia, immunohistochemistry has become a rou- tine procedure in most departments of pathology. Flow cytometry has become an efficient technique for meas- Preface uring ploidy, and molecular biological methods such as DNA and RNA hybridization and polymerase chain re- action (PCR) have made it possible to identify specific genetic markers for various hereditary, neoplastic, and infectious diseases. The importance of these innova- tions in pathology is duly recognized, but, at the same time, they have limitations, and traditional morpho- logical studies still comprise the backbone of the pathologist’s work. In this latter group of studies we in- clude electron microscopy, which has continued to be used selectively in diagnostic workups of neoplastic, re- nal, neuromuscular, infectious, hereditary, and meta- bolic diseases. In our own experience, electron micro- scopy has been especially valuable in complementing immunohistochemistry or in superseding immunohis- tochemistry when the latter is equivocal or nonspecific. Aside from the practical application to diagnostic work, electron microscopy has been a valuable tool for educating residents and staff. It reveals cells and tissues at very high magnification, making cell surfaces and in- teriors visible beyond the limits of light microscopy, a seemingly important experience in the study of normal and diseased states. The omission of this basic mor- phological step in the training and continuing educa- tion of pathologists would be, in our opinion, a serious deficiency. In this second edition, we have retained the style and core components of the first edition but have updated the text and bibliography, added new topics, and re- placed and supplemented photographs appropriately. The result has been a larger book and, we hope, one of broader applicability. G. Richard Dickersin, M.D. Boston, Massachusetts vii It goes without saying that a book of this type cannot be produced by one person, at least not within a prac- tical time frame and while simultaneously carrying out routine “service work” in a busy department of pathol- ogy. Thus, there are a number of persons who deserve special acknowledgment for their roles in making this work possible. First, Cheryl Nason and Martin Selig were at the core of the daily labor of the book. Cheryl’s mastery of the computer allowed for rough drafts, Acknowledgments countless additions and revisions, and literature searches to be accomplished in a timely manner. Her work was always outstandingly prompt and accurate, and I am most appreciative of it. Martin was a steady, consistent, right-hand man in the “rescoping,” photog- raphy, and assembly of illustrations. His skills went be- yond the purely technical ones, of which he is such a master, and included an academic familiarity with the particular morphology we were attempting to capture and portray. As will be noticed, Martin is listed as a con- tributing author of the chapter on renal glomerular dis- ease, but he also approached a similar level of involve- ment on several of the other chapters. I wish to acknowledge and thank him for the high quality of his work and for his commitment to the project. An “unsung hero” in the evolution of this book was a person whose skillful and reliable performance of rou- tine technical chores kept our electron microscopy serv- ice viable and efficient. That person is Robert Holmes. To Rob, our emphatic expression of gratitude and ap- preciation. Special appreciation also goes to the authors of Chapters 12 and 13, Shamila Mauiyyedi, Alain P. Mar- ion, Robert B. Colvin, Umberto De Girolami, and Dou- glas C. Anthony. Their expertise and contributions round out this book, making it more comprehensive and authoritative than I could possibly have hoped to accomplish myself. Finally, as for the first edition, I want to thank my wife, daughters, and son for their tolerance during weekends and vacations, when I would usually put in a few hours on “the book.” G. Richard Dickersin, M.D. Boston, Massachusetts ix Contents Preface vii Acknowledgments ix Contributors xix CHAPTER 1 Normal Cell Ultrastructure and Function 1 Cytoplasmic Organelles 1 Cytoskeleton (Cytoplasmic Matrix Structures) 4 Cytoplasmic Inclusions 4 Nuclear Organelles 4 Organization of Organelles Within the Cell 5 Cell Attachment Sites 5 CHAPTER 2 Selective Embryology 7 Embryogenesis from Fertilization Through Three Weeks 7 Differentiation of the Paraxial Mesoderm 9 Differentiation of the Intermediate Mesoderm 10 Differentiation of the Lateral Mesoderm 11 Comparison of Embryonic Mesodermal Differentiation with Embryonal Rhabdomyosarcoma, Wilms’ Tumor, and Mesothelioma 11 CHAPTER 3 Large Cell Neoplasms 27 Carcinoma 27 Adenocarcinoma (and Adenoma) 27 Squamous Cell Carcinoma 65 xi XII CONTENTS Transitional Cell (Urothelial) Carcinoma 65 Undifferentiated Carcinoma 88 Melanoma 88 Mesothelioma 88 Lymphoma 89 Histiocytic Disorders 116 Macrophagic Lesions 116 Dendritic Cell Lesions 117 Mastocytosis and Mastocytoma 124 CHAPTER 4 Small Cell Neoplasms 147 Neuroendocrine Carcinoma 147 Neuroblastoma 147 Ewing’s Sarcoma 161 Primitive Neuroectodermal Tumor 161 Embryonal and Alveolar Rhabdomyosarcoma 169 Rhabdoid Tumor 169 Nephroblastoma (Wilms’ Tumor) 169 Lymphoma (Small Cell) 197 Plasmacytoma 197 Desmoplastic Small Round Cell Tumor with Divergent Differentiation 197 Small Cell Osteosarcoma 197 Mesenchymal Chondrosarcoma 209 CHAPTER 5 Leukemias 217 Myelocytic Leukemia 217 Monocytic and Myelomonocytic Leukemia 227 Lymphocytic Leukemia 227 Erythrocytic Leukemia 227 Megakaryocytic Leukemia 234 Hairy Cell Leukemia (Leukemic Reticuloendotheliosis) 234 CHAPTER 6 Spindle Cell Neoplasms and Their Epithelioid Variants 247 Fibrous Neoplasms 247 Malignant Fibrous Histiocytoma 264 CONTENTS XIII Cartilaginous Neoplasms 278 Osteoblastoma and Osteosarcoma 278 Synovial Sarcoma 295 Adipose Neoplasms 295 Smooth Muscle Neoplasms 320 Skeletal Muscle Neoplasms 320 Vascular Neoplasms 341 Hemangiopericytoma 341 Schwannoma and Malignant Schwannoma 359 Granular Cell Tumor 359 Neurofibroma 369 Sarcomatoid (Spindle Cell) Carcinoma
Recommended publications
  • Glossary for Narrative Writing
    Periodontal Assessment and Treatment Planning Gingival description Color: o pink o erythematous o cyanotic o racial pigmentation o metallic pigmentation o uniformity Contour: o recession o clefts o enlarged papillae o cratered papillae o blunted papillae o highly rolled o bulbous o knife-edged o scalloped o stippled Consistency: o firm o edematous o hyperplastic o fibrotic Band of gingiva: o amount o quality o location o treatability Bleeding tendency: o sulcus base, lining o gingival margins Suppuration Sinus tract formation Pocket depths Pseudopockets Frena Pain Other pathology Dental Description Defective restorations: o overhangs o open contacts o poor contours Fractured cusps 1 ww.links2success.biz [email protected] 914-303-6464 Caries Deposits: o Type . plaque . calculus . stain . matera alba o Location . supragingival . subgingival o Severity . mild . moderate . severe Wear facets Percussion sensitivity Tooth vitality Attrition, erosion, abrasion Occlusal plane level Occlusion findings Furcations Mobility Fremitus Radiographic findings Film dates Crown:root ratio Amount of bone loss o horizontal; vertical o localized; generalized Root length and shape Overhangs Bulbous crowns Fenestrations Dehiscences Tooth resorption Retained root tips Impacted teeth Root proximities Tilted teeth Radiolucencies/opacities Etiologic factors Local: o plaque o calculus o overhangs 2 ww.links2success.biz [email protected] 914-303-6464 o orthodontic apparatus o open margins o open contacts o improper
    [Show full text]
  • Rush University Medical Center, May 2005
    TABLE OF CONTENTS Case # Title Page 1. Malignant Spitz’s Nevus 1 2. Giant Congenital Nevus 4 3. Methotrexate Nodulosis 7 4. Apthae with Trisomy 8–positive Myelodysplastic Syndrome 10 5. Kwashiorkor 13 6. “Unknown” 16 7. Gangrenous Cellulitis 17 8. Parry-Romberg Syndrome 21 9. Wegener’s Granulomatosis 24 10. Pediatric CTCL 27 11. Hypopigmented Mycosis Fungoides 30 12. Fabry’s Disease 33 13. Cicatricial Alopecia, Unclassified 37 14. Mastocytoma 40 15. Cutaneous Piloleiomyomas 42 16. Granular Cell Tumor 44 17. Disseminated Blastomycoses 46 18. Neonatal Lupus 49 19. Multiple Lipomas 52 20. Acroangiodermatitis of Mali 54 21. Pigmented Basal Cell Carcinoma (BCC) 57 Page 1 Case #1 CHICAGO DERMATOLOGICAL SOCIETY RUSH UNIVERSITY MEDICAL CENTER CHICAGO, ILLINOIS MAY 18, 2005 CASE PRESENTED BY: Michael D. Tharp, M.D. Lady Dy, M.D., and Darrell W. Gonzales, M.D. History: This 2 year-old white female presented with a one year history of an expanding lesion on her left cheek. There was no history of preceding trauma. The review of systems was normal. Initially the lesion was thought to be a pyogenic granuloma and treated with two courses of pulse dye laser. After no response to treatment, a shave biopsy was performed. Because the histopathology was interpreted as an atypical melanocytic proliferation with Spitzoid features, a conservative, but complete excision with margins was performed. The pathology of this excision was interpreted as malignant melanoma measuring 4.0 mm in thickness. A sentinel lymph node biopsy was subsequently performed and demonstrated focal spindle cells within the subcapsular sinus of a left preauricular lymph node.
    [Show full text]
  • A Single Case Report of Granular Cell Tumor of the Tongue Successfully Treated Through 445 Nm Diode Laser
    healthcare Case Report A Single Case Report of Granular Cell Tumor of the Tongue Successfully Treated through 445 nm Diode Laser Maria Vittoria Viani 1,*, Luigi Corcione 1, Chiara Di Blasio 2, Ronell Bologna-Molina 3 , Paolo Vescovi 1 and Marco Meleti 1 1 Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy; [email protected] (L.C.); [email protected] (P.V.); [email protected] (M.M.) 2 Private practice, Centro Medico Di Blasio, 43121 Parma; Italy; [email protected] 3 Faculty of Dentistry, University of the Republic, 14600 Montevideo, Uruguay; [email protected] * Correspondence: [email protected] Received: 10 June 2020; Accepted: 11 August 2020; Published: 13 August 2020 Abstract: Oral granular cell tumor (GCT) is a relatively rare, benign lesion that can easily be misdiagnosed. Particularly, the presence of pseudoepitheliomatous hyperplasia might, in some cases, lead to the hypothesis of squamous cell carcinoma. Surgical excision is the treatment of choice. Recurrence has been reported in up to 15% of cases treated with conventional surgery. Here, we reported a case of GCT of the tongue in a young female patient, which was successfully treated through 445 nm diode laser excision. Laser surgery might reduce bleeding and postoperative pain and may be associated with more rapid healing. Particularly, the vaporization effect on remnant tissues could eliminate GCT cells on the surgical bed, thus hypothetically leading to a lower rate of recurrence. In the present case, complete healing occurred in 1 week, and no recurrence was observed after 6 months. Laser surgery also allows the possibility to obtain second intention healing.
    [Show full text]
  • Growing Papule on the Right Shoulder of an Elderly Man
    DERMATOPATHOLOGY DIAGNOSIS CLOSE ENCOUNTERS WITH THE ENVIRONMENT Growing Papule on the Right Shoulder of an Elderly Man Campbell L. Stewart, MD; Karolyn A. Wanat, MD; Adam I. Rubin, MD copy A not B H&E, original magnification ×20. H&E, original magnification ×400. Do The best diagnosis is: a. desmoplastic trichilemmoma b. granular cell basal cell carcinoma c. granular cell tumor d. sebaceous adenoma CUTIS e. xanthogranuloma PLEASE TURN TO PAGE 392 FOR DERMATOPATHOLOGY DIAGNOSIS DISCUSSION Dr. Stewart is from the University of Washington, Seattle. Dr. Wanat is from the University of Iowa, Iowa City. Dr. Rubin is from the University of Pennsylvania, Philadelphia. The authors report no conflict of interest. Correspondence: Adam I. Rubin, MD, University of Pennsylvania, 2 Maloney Bldg, 3600 Spruce St, Philadelphia, PA 19104 ([email protected]). WWW.CUTIS.COM VOLUME 97, JUNE 2016 391 Copyright Cutis 2016. No part of this publication may be reproduced, stored, or transmitted without the prior written permission of the Publisher. Dermatopathology Diagnosis Discussion Granular Cell Basal Cell Carcinoma asal cell carcinoma (BCC) is the most com- The granules in GBCC generally are positive on peri- mon human epithelial malignancy. There are odic acid–Schiff staining.1-4 several histologic variants, the rarest being The histologic differential diagnosis for GBCC B 1 granular cell BCC (GBCC). Granular cell BCC is includes granular cell tumor as well as other tumors reported most commonly in men with a mean age that can present with granular cell changes such as of 63 years. Sixty-four percent of cases develop on ameloblastoma, leiomyoma, leiomyosarcoma, angio- the face, with the remainder arising on the chest sarcoma, malignant peripheral nerve sheath tumor, or trunk.
    [Show full text]
  • New Jersey State Cancer Registry List of Reportable Diseases and Conditions Effective Date March 10, 2011; Revised March 2019
    New Jersey State Cancer Registry List of reportable diseases and conditions Effective date March 10, 2011; Revised March 2019 General Rules for Reportability (a) If a diagnosis includes any of the following words, every New Jersey health care facility, physician, dentist, other health care provider or independent clinical laboratory shall report the case to the Department in accordance with the provisions of N.J.A.C. 8:57A. Cancer; Carcinoma; Adenocarcinoma; Carcinoid tumor; Leukemia; Lymphoma; Malignant; and/or Sarcoma (b) Every New Jersey health care facility, physician, dentist, other health care provider or independent clinical laboratory shall report any case having a diagnosis listed at (g) below and which contains any of the following terms in the final diagnosis to the Department in accordance with the provisions of N.J.A.C. 8:57A. Apparent(ly); Appears; Compatible/Compatible with; Consistent with; Favors; Malignant appearing; Most likely; Presumed; Probable; Suspect(ed); Suspicious (for); and/or Typical (of) (c) Basal cell carcinomas and squamous cell carcinomas of the skin are NOT reportable, except when they are diagnosed in the labia, clitoris, vulva, prepuce, penis or scrotum. (d) Carcinoma in situ of the cervix and/or cervical squamous intraepithelial neoplasia III (CIN III) are NOT reportable. (e) Insofar as soft tissue tumors can arise in almost any body site, the primary site of the soft tissue tumor shall also be examined for any questionable neoplasm. NJSCR REPORTABILITY LIST – 2019 1 (f) If any uncertainty regarding the reporting of a particular case exists, the health care facility, physician, dentist, other health care provider or independent clinical laboratory shall contact the Department for guidance at (609) 633‐0500 or view information on the following website http://www.nj.gov/health/ces/njscr.shtml.
    [Show full text]
  • Granular Cell Tumor of the Tongue: a Case Report with Emphasis on The
    ancer C C as & e y Ottoman, Oncol Cancer Case Rep 2015,1:1 g R o e l p o o c r t n Oncology and Cancer Case O ISSN: 2471-8556 Reports ResearchCase Report Article OpenOpen Access Access Granular Cell Tumor of the Tongue: A Case Report with Emphasis on the Diagnostic and Therapeutic Proceedings Bacem AE Ottoman* 1Department of Medicine, Division of Hematology/Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA 2Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA Abstract Granular cell tumor (GCT), eponymically Abrikossoff’s myoblastoma, is an uncommon asymptomatic benign neoplasm with controversial etiopathogenia. The tumor typically reveals itself as a well-circumscribed, slowly growing nodular mass. Tongue is most commonly preferred in the head and neck region. The conventional size of the granular cell tumor is usually measuring 2-3 centimeters in its greater diameter. The granular cell tumor can taint all age groups, with a peak between 40 and 60 years. This report introduces, however, a case of GCT of the tongue in a much younger female that was totally excised. The clientele has shown up after 1, 3 and 6 months for follow-up. In the head and neck region, there was no evidence of either recurrence or metachronous clinical manifestations of any similar lesions; at the clinical and sonographical assessment. Keywords: Abrikossoff’s tumor; Granular cell tumor; Myoblastoma; Tongue ultrasound Introduction In 1926, Alexei Ivanovich Abrikossoff has introduced the granular cell tumor (GCT), designating it as a myoblastoma. GCT is an uncommon asymptomatic sessile nodule with typical pink overlying mucosa.
    [Show full text]
  • 1 Pulmonary Pathology Journal Club
    Pulmonary Pathology Journal Club November 25, 2019 (Joanne) Eunhee S. Yi, MD and Matt Cecchini, MD, PhD Mayo Clinic, Rochester, MN Table of Contents Articles for Discussion Page 4 Larsen BT et al. Clinical and histopathologic features of immune check point inhibitor-related pneumonitis. Am J Surg Pathol 2019;43:1331-40 Page 5 Offin M et al. Current RB and TP53 alterations define a subset of EGFR-mutant lung cancers at risk for histologic transformation and inferior clinical outcomes. J Thorac Oncol 2019;14: 1784-93 Page 6 Roschel FM et al. Feasibility of perioperative-computed tomography of human lung cancer specimens. A pilot study. Arch Pathol Lab Med 2019;143:319-25 Page 7 Zhang et al. Clinical significance of the cribriform pattern in invasive adenocarcinoma of the lung. J Clin Pathol 2019;72:682-8 Page 8 Chae KW et al. Clinical and immunological implications of frameshift mutations in lung cancer. J Thorac Oncol 2019;14:1807-17 Articles for Notation Neoplastic Page 9 Choe EA et al. Dynamic changes in PD-L1 expression and CD8+ T cell infiltration in non-small cell lung cancer following chemoradiation therapy. Lung Cancer 2019;136:30-6 Page 10 Jin J et al. Diminishing microbiome richness and distinction in the lower respiratory tract of lung cancer patients: A multiple comparative study design with independent validation. Lung Cancer 2019;136:129-35 Page 10 Davis R et al. Pulmonary granular cell tumors. A study of 4 cases including a malignant phenotype. Am J Surg Pathol 2019;43:1397-1402 Page 11 Song Z et al.
    [Show full text]
  • Scrotal Granular Cell Tumor: a Case Report
    Case Report Open Access J Surg Volume 4 Issue 2 - May 2017 Copyright © All rights are reserved by Brano Djenic DOI: 10.19080/OAJS.2017.04.555634 Scrotal Granular Cell Tumor: A Case Report Brano Djenic1* and Kaveh Homayoon2 1General Surgery Resident, Department of Surgery, Maricopa Medical Center, USA 2Department of Surgery, Division of Urology, Maricopa Medical Center, USA Submission: April 26, 2017; Published: May 05, 2017 *Corresponding author: Brano Djenic, Department of Surgery, Maricopa Medical Center, Phoenix, AZ 85008, USA, Tel: ; Email: Introduction wanted scrotal mass removed, as well. Excision of the scrotal Previously referred to as granular cell myblastoma, granular mass was uneventful. Primary closure of the scrotum was successful. Post-operative visits revealed nicely healing incision schwanomma, the Abrikossoff’s tumor or today known as cell neuroma, granular cell neurofibroma andgranular cell without drainage, erythema or pain. Pathological reports revealed a benign granular cell tumor. Patient and family are granular cell tumor (GCT), is classified as a neural lesion that aware of the benign nature of the lesion as well as its chance for tumors. Although they can occur in both males and females is very distinct from neurofibromas, schwanommas or muscle recurrence. Follow up is on as needed basis. and at any age, they are more commonly seen in females (2:1) Discussion commonly in African Americans andthey are rare in children. in fourth, fifth or sixth decade. Granular cell tumors occur more Head and neck GCTs make up 75%, with tongue being the most common location; reports of breast lesions, GI tact involvement, and miscellaneous skin and soft tissue GCTs have been reported.
    [Show full text]
  • Subcutaneous, Mucocutaneous, and Mucous Membrane Tumors
    DERMATOPATHOLOGY DIAGNOSIS Subcutaneous, Mucocutaneous, and Mucous Membrane Tumors Michael Lor, BA; Logan Thomas, MD; Steven Ohsie, MD; Scott Binder, MD; Daniel Behroozan, MD Eligible for 1 MOC SA Credit From the ABD This Dermatopathology Diagnosis in our print edition is eligible for 1 self-assessment credit for Maintenance of Certification from the American Board of Dermatology (ABD). After completing this activity, diplomates can visit the ABD website (http://www.abderm.org) to self-report the credits under the activity title “Cutis Dermatopathology Diagnosis.” You may report the credit after each activity is completed or after accumulating multiple credits. A 26-year-old woman with a history of dysplastic nevi with severe atypia presented with a growth on the lower lip of 3 years’ duration. She deniedcopy any inciting event, such as prior trauma to the area, and reported that the lesion had been asymptomatic without a notable change in size. Physical examination revealed a translucent, soft, com- pressible cystic papule on the left inferior vermilion lip. Wide local excisionnot following incisional biopsy was performed. Six months later, the patient returned to our clinic with a lesion on the right lateral tongue of 6 weeks’ duration as well as a 1-cm subcutaneous cyst in the left axilla of Do6 months’ duration. Excisional biopsies of both lesions were H&E, original magnification ×10. performed for histopathologic analysis. Pathology results were similar among the lip, tongue, and axillary lesions. Immunohistochemistry revealed strong positive staining with antibodies to S-100 protein, SOX10, and CD68. THE BEST DIAGNOSIS IS: a. atypical fibroxanthoma CUTIS b.
    [Show full text]
  • El Paso Community College Syllabus Part II Official Course Description
    DNTA 1447; Revised Fall 2019/Spring 2020 El Paso Community College Syllabus Part II Official Course Description SUBJECT AREA Dental Assisting COURSE RUBIC AND NUMBER DNTA 1447 COURSE TITLE Advanced Dental Science COURSE CREDIT HOURS 4 4 : 0 Credits Lec Lab I. Catalog Description Provides an advanced study of anatomical systems, pharmacology, oral pathology, and developmental abnormalities. A grade of "C" or better is required in this course to take the next course. (4:0). II. Course Objectives Upon satisfactory completion of the course, the student will be able to: PART I: PHARMACOLOGY A. Unit I. Information, Sources, and Regulatory Agencies 1. Define the term "drug" as used in medical treatment. 2. Give four reasons why knowledge about drugs is important in the practice of dentistry. 3. Describe the difference between over-the-counter (OTC) and prescription drugs. 4. Define and differentiate between the chemical, generic, and trade names for drugs. 5. Tell when a pharmacist may substitute a drug from one company with a similar product from another company. 6. Utilize the Physician's Desk Reference for Prescription Drugs, Physician's Desk Reference for Non-prescription Drugs and computer programs found on the clinic computer in the Dental Hygiene Clinic, room A-110I, to determine if a medication that the patient might be taking will influence the dental treatment. 7. Describe the functions of the Food and Drug Administration (FDA) and the Drug Enforcement Agency (DEA). 8. Describe what is considered a controlled substance, whether the controlled. 9. Substance can be legally dispensed, and how the DEA controls those substances it considers do have some medical value.
    [Show full text]
  • Ultrastructural to Biobanks Is Created
    374A ANNUAL MEETING ABSTRACTS processing protocols, and advanced databases, in comparison with clinical biobanks. 1701 Whole Slide Imaging Digital Pathology: A Pilot Study Using Paired One emerging strategy to enhance quality and capacity in research biobanking is to Subspecialist Correlations ‘repatriate’ aspects to pathology. DC Wilbur, K Madi, RB Colvin, LM Duncan, WC Faquin, JA Ferry, MP Frosch, SL Design: The British Columbia (BC) BioLibrary model (figure 1) combines: 1) Houser, RL Kradin, GY Lauwers, DN Louis, EJ Mark, M Mino-Kenudson, J Misdraji, specialized BSp collection units (BCU) embedded within clinical pathology departments GP Nielsen, MB Pitman, A Rahemtullah, AE Rosenberg, RN Smith, JR Stone, RH with trained personnel, 2) a BSp catalogue of consented research study donor lists, 3) a Tambouret, C-L Wu, RH Young, A Zembowicz, W Klietmann. Massachusetts General BSp distribution system in parallel with analysis capacity, and 4) oversight through an Hospital, Boston, MA; University Federal de Rio de Janeiro, Rio de Janeiro, Brazil; interdisciplinary governance structure and molding by public deliberation. Harvard Medical School, Boston, MA; Corista LLC, Concord, MA. Background: Whole slide imaging technology offers promise for rapid Internet- based telepathology consultations between institutions. Technical issues, pathologist adaptability, and morphologic pitfalls inherent to this process have not been well characterized. Design: Histopathology slides of diseases from a variety of anatomic sites with reference diagnoses were selected by an outside laboratory. Virtual slides were made using a Zeiss Mirax scanner. Virtual and glass slides were diagnosed independently by 2 subspecialty pathologists appropriate for each anatomic site. Reference diagnoses were compared to virtual and glass slide interpretations, and correlation data was tabulated.
    [Show full text]
  • 2011 Board Review Course
    2011 Board Review Course 48th Annual Meeting October 20-23, 2011 Sheraton Seattle Seattle, Washington 2011 Board Review The American Society of Dermatopathology Faculty: Thomas N. Helm, MD, Course Director State University of New York at Buffalo Alina Bridges, DO Mayo Clinic, Rochester Klaus J. Busam, MD Memorial Sloan-Kettering Cancer Center Loren E. Clarke, MD Penn State Milton S. Hershey Medical Center/College of Medicine Tammie C. Ferringer, MD Geisinger Medical Center Darius R. Mehregan, MD Pinkus Dermatopathology Lab PC Diya F. Mutasim, MD University of Cincinnati Rajiv M. Patel, MD University of Michigan Margot S. Peters, MD Mayo Clinic, Rochester Garron Solomon, MD CBLPath, Inc. COURSE OBJECTIVES Upon completion of this course, participants should be able to: Identify board examination requirements. Utilize new technology to assist with various diagnoses and treatment methods. Structure and Function of the Skin Alina Bridges, DO Mayo Clinic, Rochester Structure and Function of the Epidermis Alina G. Bridges, D.O. Assistant Professor, Department of Dermatopathology, Division of Dermatopathology and Cutaneous Immunopathology, Mayo Clinic, Rochester, MN I. Functions A. Protection B. Sensory reception C. Thermal regulation D. Nutrient (Vitamin D) metabolism E. Immunologic surveillance 1.Keratinocytes produce interleukins, colony stimulating factors, tumor necrosis factors, transforming growth factors and growth F. Repair II. Epidermis A. Derived from ectoderm B. Keratinizing stratified squamous epithelium from which arise cutaneous appendages (sebaceous glands, nails and apocrine and eccrine sweat glands) 1. Rete 2. Dermal papillae C. Comprises the following layers a) Stratum germinativum (Basal cell layer) b) Stratum spinosum (Spinous Cell layer) c) Stratum granulosum (Granular layer) d) Stratum corneum (Horny cell layer) e) Stratum lucidum present in areas where the stratum corneum is thickest, such as the palms and soles.
    [Show full text]